{
     "PMID": "7529902",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19950210",
     "LR": "20151119",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "177",
     "IP": "1-2",
     "DP": "1994 Aug 15",
     "TI": "Changes in alpha 1-adrenergic neurotransmission alter the number of somatostatin receptors in the rat hippocampus.",
     "PG": "107-10",
     "AB": "The administration of an i.p. dose of phenylephrine (2 mg/kg) increased the number of [125I]Tyr11-somatostatin ([125I]Tyr11-SS) receptors and decreased their apparent affinity in rat hippocampal membranes 7 h after its injection. Prazosin (20 mg/kg, i.p.) administered 1 h before phenylephrine reversed effects of the latter on SS binding. Prazosin alone decreased the number of SS receptors without changing the affinity. The addition of phenylephrine or prazosin (10(-5) M) to the incubation medium did not change the SS binding characteristics. The present results support the notion that the alpha 1-adrenergic system regulates the binding of SS to its specific receptors in rat hippocampus.",
     "FAU": [
          "Lopez-Sanudo, S",
          "Arilla, E"
     ],
     "AU": [
          "Lopez-Sanudo S",
          "Arilla E"
     ],
     "AD": "Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Alcala, Madrid, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Adrenergic alpha-1 Receptor Agonists)",
          "0 (Adrenergic alpha-1 Receptor Antagonists)",
          "0 (Receptors, Adrenergic, alpha-1)",
          "0 (Receptors, Somatostatin)",
          "1F7A44V6OU (Colforsin)",
          "1WS297W6MV (Phenylephrine)",
          "51110-01-1 (Somatostatin)",
          "59481-27-5 (somatostatin, Tyr(11)-)",
          "E0399OZS9N (Cyclic AMP)",
          "EC 4.6.1.1 (Adenylyl Cyclases)",
          "TBT296U68M (1-Methyl-3-isobutylxanthine)",
          "XM03YJ541D (Prazosin)"
     ],
     "SB": "IM",
     "MH": [
          "1-Methyl-3-isobutylxanthine/pharmacology",
          "Adenylyl Cyclases/metabolism",
          "Adrenergic alpha-1 Receptor Agonists",
          "Adrenergic alpha-1 Receptor Antagonists",
          "Animals",
          "Colforsin/pharmacology",
          "Cyclic AMP/physiology",
          "Down-Regulation/*drug effects",
          "Enzyme Activation/drug effects",
          "Hippocampus/*chemistry/physiology",
          "Learning/physiology",
          "Phenylephrine/*pharmacology",
          "Prazosin/pharmacology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Adrenergic, alpha-1/*physiology",
          "Receptors, Somatostatin/*metabolism",
          "Signal Transduction/drug effects",
          "Somatostatin/analogs & derivatives/metabolism/physiology"
     ],
     "EDAT": "1994/08/15 00:00",
     "MHDA": "1994/08/15 00:01",
     "CRDT": [
          "1994/08/15 00:00"
     ],
     "PHST": [
          "1994/08/15 00:00 [pubmed]",
          "1994/08/15 00:01 [medline]",
          "1994/08/15 00:00 [entrez]"
     ],
     "AID": [
          "0304-3940(94)90056-6 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 1994 Aug 15;177(1-2):107-10.",
     "term": "hippocampus"
}